CLEVELAND--(BUSINESS WIRE)--Arteriocyte Medical Systems announced today that the company has struck a Strategic Partnership with Medtronic that includes the acquisition of the Magellan Platelet Business, a worldwide exclusive distribution agreement in the Cardiac Surgery Market for the next five years, and a manufacturing services agreement for the Magellan products. Medtronic’s Cardiac Surgery sales force includes 80 representatives spread throughout North America and Europe and has placed the Magellan system in over 400 surgical centers.
